Sodium-Glucose Cotransporter 2 Inhibitors: A Scoping Review of the Positive Implications on Cardiovascular and Renal Health and Dynamics for Clinical Practice

Cardiorenal benefits of sodium-glucose cotransporter 2 inhibitors (SGLT2is) have been demonstrated in patients with type 2 diabetes in multiple trials. We aim to provide a comprehensive review of the role of SGLT2i in cardiovascular disease. Reducing blood glucose to provide more effective vascular...

Descripción completa

Detalles Bibliográficos
Autores principales: Erdem, Saliha, Titus, Anoop, Patel, Dhruvil, Patel, Neel N, Sattar, Yasar, Glazier, James, Alraies, M. Chadi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166724/
https://www.ncbi.nlm.nih.gov/pubmed/37182087
http://dx.doi.org/10.7759/cureus.37310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166724/
https://www.ncbi.nlm.nih.gov/pubmed/37182087
http://dx.doi.org/10.7759/cureus.37310

Ejemplares similares